CellCor™ MSC CD AOF (GMP)
Product Code:
XCE-YSP023
XCE-YSP023
Regulatory Status:
GMP grade
GMP grade
Shipping:
Dry Ice
Dry Ice
Storage:
<-20°C
<-20°C
No additional charges, what you see is what you pay! *
| Code | Size | Price |
|---|
| XCE-YSP023-500mL | 500 mL | £693.00 |
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges to UK mainland customers, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: Republic of Korea.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
- Further Information
- Documents
- References
- Show All
Further Information
Description:
In order to grow optimal mesenchymal stem cells, it is important to select the right media that can affect cell characteristics as they should. CellCor™ MSC CD AOF is composed of chemically defined components and is the most ideal product to control culture conditions. CellCor™ MSC CD AOF can be used to cultivate stably until the second half of the subculture and maintains stable stemness (differentiation and marker expression). In addition, it maintains low aging and high genetic stability of cells and is applicable for mesenchymal stem cells derived from various tissues (Adipose, Bone marrow, Cord blood, Wharton jelly, etc.), and is applicable to stem cell-derived exosomes production and research.
HS Code:
3821
Shelf Life:
12 months
References
- Kim, J.Y., Rhim, W-K., Seo, H.J., Lee, J.Y., Park, C.G., Han, D.K.; Comparative Analysis of MSC-Derived Exosomes Depending on Cell Culture Media for Regenerative Bioactivity; Tissue Eng Regen Med; 2021; 18(3); 355?367
- Kim, J.Y., Rhim, W.K., Cha, S.G., Woo, J., Lee, J.Y., Park, C.G., Han, D.K.; Bolstering the secretion and bioactivities of?umbilical cord MSC-derived extracellular vesicles with?3D culture and priming in chemically defined media; Nano Convergence; 2022; 9; 57
- Lee, J.Y., Kang, M.H., Jang J.E., Lee, J.E., Yang, Y., Choi, J.Y., Kang, H.S., Lee, U., Choung, J.W., Jung, H., Yoon, Y.C., Jung, K.H., Hong, S.S., Yi, E.C., Park, S.G.; Comparative analysis of mesenchymal stem cells cultivated in serum free media; Sci Rep ; 2022; 12, 8620
- Martin, K.E., Kalelkar, P.P., Coronel, M.M., Theriault, H.S., Schneider, R.S., Garcia, A.J.; Host type 2 immune response to xenogeneic serum components impairs biomaterial-directed osteo-regenerative therapies; Biomaterials; 2022; 286;
- Mo, Y., Kang, H., Band, J.Y., Shin, J.W., Kim, H.Y., Cho, S.H., Kang, H.R.; Intratracheal administration of mesenchymal stem cells modulates lung macrophage polarization and exerts anti?asthmatic effects; Sci Rep ; 2022; 12, 11728
- Mo, Y., Kim, Y., Bang, J.Y., Jung, J., Lee, C.G., Elias, J.A., Kang, H.R.; Mesenchymal Stem Cells Attenuate Asthmatic Inflammation and Airway Remodeling by Modulating Macrophages/Monocytes in the IL-13-Overexpressing Mouse Model; Immune Network; 2022; 22(5)